Although MES reprogramming was traditionally considered as a phenomenon mainly unique to epithelial cancers, the MES state of GBM has been identified through molecular clustering whereby NF1 loss appears to be a consistent genetic lesion [51]. This evidence concerns the gene NF1 and glioblastoma.